Marex Group Résultats passés
Passé contrôle des critères 5/6
Marex Group a connu une croissance annuelle moyenne de ses bénéfices de 35.3%, tandis que le secteur Capital Markets a vu ses bénéfices augmenter de en hausse à 7% par an. Les revenus ont augmenté de en hausse à un taux moyen de 27.3% par an. Le rendement des capitaux propres de Marex Group est 20.9% et ses marges nettes sont de 10.8%.
Informations clés
35.35%
Taux de croissance des bénéfices
38.24%
Taux de croissance du BPA
| Capital Markets Croissance de l'industrie | 10.26% |
| Taux de croissance des recettes | 27.33% |
| Rendement des fonds propres | 20.92% |
| Marge nette | 10.77% |
| Dernière mise à jour des bénéfices | 30 Jun 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • Sep 03
MRX: Acquisition Momentum And Higher Margins Will Support Further Upside
Analysts have raised the Marex Group price target from $72.38 to $79.88, citing updated assumptions for a smaller revenue decline, a slightly higher profit margin, a modestly higher discount rate, and a slightly lower future P/E multiple. What’s in the News for Marex Group Marex Group reported Q2 2026 revenue of US$695.8 million, which was 39% higher year over year and more than 11% above analyst estimates.
Mise à jour du récit • Aug 20
MRX: Higher Profitability And Volatility-Driven Trading Volumes Will Support Upside
Marex Group's analyst fair value estimate has been revised from $75.00 to $100.00 as analysts factor in slightly higher assumed profit margins and a higher future P/E multiple, despite modestly softer projected revenue growth and a marginally higher discount rate. What’s in the News for Marex Group Marex Group reported Q2 2026 revenue of about US$696 million, up 39% year over year, with growth coming from all four business segments.Seeking Alpha • Aug 17
Recent Results From Marex Group Impress, But Some Risks Are Rising
Summary Marex Group delivered record H1 2026 revenue and profitability, with adjusted profit before tax of $318.6 million, driving an 18% stock surge on August 12. MRX's rapid acquisition strategy fueled significant YoY segment revenue growth, notably 134% in Market Making and 35% in Agency and Execution. Operational efficiency improved: adjusted profit margin rose 200 bps to 23%, and adjusted ROE reached 37.5%, nearly 700 bps higher YoY. Despite valuation concerns and increased risk from acquisitions and debt, I maintain a Buy rating on MRX given sustained earnings momentum. Read the full article on Seeking Alpha
Mise à jour du récit • Aug 06
MRX: Rich Earnings Multiple Will Confront Weaker Revenue And Index Exclusion Risk
Analysts have raised their price target for Marex Group from about $37.00 to roughly $44.00, reflecting updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News Marex Group completed the acquisition of European equity derivatives market maker Webb Traders, which focuses on single stock options for European and US mid and large cap equities.Mise à jour du récit • Jul 23
MRX: Bermuda Move And Digital Collateral Shift Will Constrain Upside Potential
Analysts have raised their price target for Marex Group from $59.75 to $72.38, citing updated assumptions around revenue contraction, profit margin, and future P/E that together support a higher fair value estimate. What’s in the News for Marex Group Marex Group is allowing derivatives clients to post USDC stablecoin as initial margin collateral using Coinbase infrastructure, following a December 2025 CFTC no action letter that permits futures commission merchants to accept certain digital assets as margin.Mise à jour du récit • Jul 08
MRX: Bermuda Redomiciliation Will Limit Future Upside From Current Levels
Analysts have nudged their price target for Marex Group higher from $57.13 to $59.75, citing updated assumptions that combine slightly softer revenue expectations with a small improvement in projected profit margins and a modestly higher future P/E multiple. What’s in the News for Marex Group Marex Group Limited completed its redomiciliation from England and Wales to Bermuda on July 1, 2026, following shareholder approval on May 21, 2026, and English High Court sanction on June 26, 2026.Mise à jour du récit • Jun 22
MRX: Higher Fair Value And Market Volatility Tailwinds Will Support Upside
Analysts have raised their price target for Marex Group from $66.00 to $75.00, citing updated assumptions around revenue trends, a slightly higher discount rate, and modestly adjusted profit margin and P/E expectations. What’s in the News for Marex Group Night Watch Investment Management identified Marex Group plc as its largest holding, highlighting the futures clearing business as critical financial infrastructure with a strong and defensible market position, and pointing to earnings that have grown roughly 7x over the past five years, according to recent commentary from the firm.Mise à jour du récit • Jun 05
MRX: Levmet Deal And Bermuda Move Will Support Measured Future Upside
Analysts have maintained their $57.13 price target for Marex Group, reflecting steady assumptions for its discount rate, an expected revenue decline of 7.25%, a profit margin of 20.12% and a future P/E of 11.49x. What's in the News Marex Group agreed to acquire Levmet, a Monaco based liquidity provider focused on base and ferrous metals, energy, and power.Mise à jour du récit • May 22
MRX: Q1 2026 Guidance And Dividend Outlook Will Support Measured Upside
Analysts have raised their price target for Marex Group from $55.00 to $57.13, citing updated assumptions on revenue trends, profit margins and future P/E expectations. What's in the News Marex Group plc issued earnings guidance for the first quarter of 2026, with expected revenue in a range of $667 million to $697 million for the period ended March 31, 2026, compared with Q1 2025 revenue of $467 million (Key Developments).Mise à jour du récit • May 07
MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside
Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).Mise à jour du récit • Apr 22
MRX: Higher Fair Value And Lower Future P/E Will Support Upside
Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).Mise à jour du récit • Apr 07
MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook
Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.Mise à jour du récit • Mar 24
MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares
Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.Mise à jour du récit • Mar 09
MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside
Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.Mise à jour du récit • Feb 23
MRX: Rising Trading Volumes And Volatility Will Support Earnings Power
Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.Mise à jour du récit • Feb 07
MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward
The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.Mise à jour du récit • Jan 23
MRX: US Expansion And Higher Trading Volumes Will Support Future Upside
Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.Mise à jour du récit • Jan 08
MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim
Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.Mise à jour du récit • Dec 23
MRX Will Benefit From Expanding US Structured Products And Margin Resilience
Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.Mise à jour du récit • Dec 09
MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits
Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.Mise à jour du récit • Nov 25
MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk
Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.Mise à jour du récit • Nov 06
MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits
Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.Mise à jour du récit • Oct 23
Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook
Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.Mise à jour du récit • Oct 08
Digitalization And M&A Will Unlock Global Market Potential
Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).
Nouveau récit • Apr 27
Acquisitions Will Fuel APAC And Middle East Expansion
Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Marex Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 26 | 3,489 | 376 | 1,485 | 0 |
| 31 Mar 26 | 3,266 | 334 | 1,386 | 0 |
| 31 Dec 25 | 2,870 | 294 | 1,250 | 0 |
| 30 Sep 25 | 2,668 | 266 | 1,156 | 0 |
| 30 Jun 25 | 2,608 | 251 | 1,105 | 0 |
| 31 Mar 25 | 2,530 | 234 | 1,052 | 0 |
| 31 Dec 24 | 2,357 | 205 | 990 | 0 |
| 30 Sep 24 | 2,142 | 189 | 939 | 0 |
| 30 Jun 24 | 1,883 | 134 | 1,283 | 0 |
| 31 Mar 24 | 1,849 | 140 | 1,028 | 0 |
| 31 Dec 23 | 1,882 | 128 | 799 | 0 |
| 30 Sep 23 | 1,092 | 140 | 737 | 0 |
| 30 Jun 23 | 1,818 | 139 | 451 | 0 |
| 31 Mar 23 | 1,570 | 115 | 451 | 0 |
| 01 Jan 23 | 1,010 | 92 | 459 | 0 |
| 01 Jan 22 | 825 | 57 | 371 | 0 |
| 31 Dec 20 | 758 | 44 | 277 | 0 |
| 31 Dec 19 | 549 | 36 | 212 | 0 |
| 31 Dec 18 | 384 | 10 | 0 | 0 |
| 31 Dec 17 | 318 | 18 | 0 | 0 |
| 31 Dec 16 | 328 | 20 | 0 | 0 |
| 31 Dec 15 | 346 | 18 | 0 | 0 |
Des revenus de qualité: MRX a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de MRX sont plus élevées que l'année dernière MRX. (10.8%) sont plus élevées que l'année dernière (9.6%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de MRX ont augmenté de manière significative de 35.3% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de MRX au cours de l'année écoulée ( 49.7% ) dépasse sa moyenne sur 5 ans ( 35.3% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices MRX au cours de l'année écoulée ( 49.7% ) a dépassé celle du secteur Capital Markets 32.9%.
Rendement des fonds propres
ROE élevé: Bien que le retour sur capitaux propres ( 20.92% ) de MRX soit élevé, cette mesure est faussée en raison de son niveau d'endettement élevé.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/13 12:45 |
| Cours de l'action en fin de journée | 2026/09/11 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Marex Group Limited est couverte par 11 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Benjamin Budish | Barclays |
| Christopher Allen | Citigroup Inc |
| Alexander Blostein | Goldman Sachs |